SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001799191-23-000044
Filing Date
2023-09-06
Accepted
2023-09-06 16:07:37
Documents
13
Period of Report
2023-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K toi-20230906.htm   iXBRL 8-K 30468
  Complete submission text file 0001799191-23-000044.txt   202057

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20230906.xsd EX-101.SCH 2306
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20230906_def.xml EX-101.DEF 15976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20230906_lab.xml EX-101.LAB 30813
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20230906_pre.xml EX-101.PRE 16714
7 EXTRACTED XBRL INSTANCE DOCUMENT toi-20230906_htm.xml XML 4189
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 231239196
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine